9
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Chaetocin-mediated SUV39H1 inhibition targets stemness and oncogenic networks of diffuse midline gliomas and synergizes with ONC201.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Diffuse intrinsic pontine gliomas (DIPG/DMG) are devastating pediatric brain tumors with extraordinarily limited treatment options and uniformly fatal prognosis. Histone H3K27M mutation is a common recurrent alteration in DIPG and disrupts epigenetic regulation. We hypothesize that genome-wide H3K27M-induced epigenetic dysregulation makes tumors vulnerable to epigenetic targeting.

          Related collections

          Author and article information

          Journal
          Neuro Oncol
          Neuro-oncology
          Oxford University Press (OUP)
          1523-5866
          1522-8517
          Apr 05 2024
          : 26
          : 4
          Affiliations
          [1 ] Brain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
          [2 ] Department of Neurology and Rehabilitation Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
          [3 ] Department of Pediatrics, University of Cincinnati and Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
          [4 ] Department of Pediatrics, Division of Pediatric Hematology-Oncology, University of Michigan School of Medicine, Ann Arbor, Michigan, USA.
          Article
          7452742
          10.1093/neuonc/noad222
          10995509
          38011799
          94637761-6089-44c5-8973-cbfd00c95f17
          © The Author(s) 2023. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
          History

          D2 dopamine receptor (DRD2) signaling,H3K9 methyltransferase SUV39H1,chaetocin,diffuse intrinsic pontine glioma (DIPG/DMG),small-molecule epigenetic compound screen,stemness and oncogenic networks

          Comments

          Comment on this article